ASX - By Stock
|
IMU |
Re:
Ann: Imugene and Kincell Bio Announce Strategic Partnership
|
|
dealer64
|
144 |
64K |
10 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
144
|
64K
|
10
|
|
ASX - By Stock
|
ASM |
Re:
Ann: Response to Aware Query
|
|
dealer64
|
20 |
8.2K |
2 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
20
|
8.2K
|
2
|
|
ASX - By Stock
|
ASM |
Re:
ASM Chart Thread
|
|
dealer64
|
11K |
4.0M |
3 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
11K
|
4.0M
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
dealer64
|
13K |
6.4M |
31 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
13K
|
6.4M
|
31
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
dealer64
|
23K |
11M |
3 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
23K
|
11M
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: ADVENT-AML Phase 1B clinical trial open to enrolment
|
|
dealer64
|
24 |
7.5K |
4 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
24
|
7.5K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
dealer64
|
23K |
11M |
55 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
23K
|
11M
|
55
|
|
ASX - By Stock
|
CHM |
Re:
Ann: ADVENT-AML Phase 1B clinical trial open to enrolment
|
|
dealer64
|
24 |
7.5K |
3 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
24
|
7.5K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: ADVENT-AML Phase 1B clinical trial open to enrolment
|
|
dealer64
|
24 |
7.5K |
2 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
24
|
7.5K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Presentation to JPMorgan Healthcare Conference
|
|
dealer64
|
85 |
52K |
7 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
85
|
52K
|
7
|
|
ASX - By Stock
|
CHM |
Re:
Ann: CHM Secures Further $1M Investment
|
|
dealer64
|
15 |
5.8K |
8 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
15
|
5.8K
|
8
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
dealer64
|
428 |
147K |
4 |
30/12/23 |
30/12/23 |
ASX - By Stock
|
428
|
147K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Completion of Entitlement Offer
|
|
dealer64
|
44 |
12K |
5 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
44
|
12K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Completion of Entitlement Offer
|
|
dealer64
|
44 |
12K |
8 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
44
|
12K
|
8
|
|
ASX - By Stock
|
CHM |
SPP
|
|
dealer64
|
3 |
731 |
2 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
3
|
731
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
dealer64
|
13K |
6.4M |
61 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
13K
|
6.4M
|
61
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33 VAXINIA Study Update - Positive Early Signals
|
|
dealer64
|
315 |
145K |
67 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
315
|
145K
|
67
|
|
ASX - By Stock
|
ASM |
Re:
ASM Chart Thread
|
|
dealer64
|
11K |
4.0M |
1 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
11K
|
4.0M
|
1
|
|
ASX - By Stock
|
ASM |
Re:
ASM Chart Thread
|
|
dealer64
|
11K |
4.0M |
0 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
11K
|
4.0M
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Entitlement Offer Documents
|
|
dealer64
|
11 |
3.6K |
1 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
11
|
3.6K
|
1
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
dealer64
|
32K |
15M |
8 |
29/10/23 |
29/10/23 |
Charts
|
32K
|
15M
|
8
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
dealer64
|
32K |
15M |
47 |
28/10/23 |
28/10/23 |
Charts
|
32K
|
15M
|
47
|
|
ASX - By Stock
|
ASM |
Re:
Relevant Media
|
|
dealer64
|
3.2K |
1.1M |
1 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
3.2K
|
1.1M
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene B Cell & OV Platforms Featured at ESMO Congress
|
|
dealer64
|
188 |
78K |
8 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
188
|
78K
|
8
|
|
ASX - By Stock
|
ATC |
Re:
Ann: Altech - Optimised Design of CERENERGY Battery Pack
|
|
dealer64
|
11 |
4.8K |
6 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
11
|
4.8K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
Ann: New data for Phase 1A CLTX CAR T brain cancer clinical trial
|
|
dealer64
|
75 |
25K |
12 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
75
|
25K
|
12
|
|
ASX - By Stock
|
ASM |
Re:
ASM Chart Thread
|
|
dealer64
|
11K |
4.0M |
3 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
11K
|
4.0M
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Thoughts on IMUOD?
|
|
dealer64
|
209 |
102K |
4 |
20/08/23 |
20/08/23 |
ASX - By Stock
|
209
|
102K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
How's the Capital Raise Going to Work?
|
|
dealer64
|
138 |
45K |
3 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
138
|
45K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: CHIMERIC RECEIVES $3.06M R&D TAX INCENTIVE
|
|
dealer64
|
35 |
11K |
0 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
35
|
11K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Athenex submits Avecho's phytonadione to FDA pre-IND
|
|
dealer64
|
68 |
15K |
7 |
13/01/23 |
13/01/23 |
ASX - By Stock
|
68
|
15K
|
7
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Athenex submits Avecho's phytonadione to FDA pre-IND
|
|
dealer64
|
68 |
15K |
10 |
13/01/23 |
13/01/23 |
ASX - By Stock
|
68
|
15K
|
10
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho receives ethics approval for Phase III CBD trial
|
|
dealer64
|
71 |
21K |
1 |
04/01/23 |
04/01/23 |
ASX - By Stock
|
71
|
21K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho receives ethics approval for Phase III CBD trial
|
|
dealer64
|
71 |
21K |
1 |
01/01/23 |
01/01/23 |
ASX - By Stock
|
71
|
21K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho receives ethics approval for Phase III CBD trial
|
|
dealer64
|
71 |
21K |
1 |
01/01/23 |
01/01/23 |
ASX - By Stock
|
71
|
21K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho receives ethics approval for Phase III CBD trial
|
|
dealer64
|
71 |
21K |
5 |
01/01/23 |
01/01/23 |
ASX - By Stock
|
71
|
21K
|
5
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho receives ethics approval for Phase III CBD trial
|
|
dealer64
|
71 |
21K |
1 |
31/12/22 |
31/12/22 |
ASX - By Stock
|
71
|
21K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho receives ethics approval for Phase III CBD trial
|
|
dealer64
|
71 |
21K |
7 |
31/12/22 |
31/12/22 |
ASX - By Stock
|
71
|
21K
|
7
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho receives ethics approval for Phase III CBD trial
|
|
dealer64
|
71 |
21K |
5 |
30/12/22 |
30/12/22 |
ASX - By Stock
|
71
|
21K
|
5
|
|
Charts
|
AVE |
Re:
AVE + AVEO Charts
|
|
dealer64
|
67 |
20K |
5 |
05/04/22 |
05/04/22 |
Charts
|
67
|
20K
|
5
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Appendix 4D and Half-year Financial Report
|
|
dealer64
|
20 |
5.8K |
2 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
20
|
5.8K
|
2
|
|
Charts
|
IXIC |
Re:
NASDAQ futures
|
|
dealer64
|
2 |
1.9K |
0 |
15/03/21 |
15/03/21 |
Charts
|
2
|
1.9K
|
0
|
|
ASX - By Stock
|
BOQ |
Re:
where do the new shares get allocated
|
|
dealer64
|
1 |
771 |
0 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
1
|
771
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho signs Term Sheet for Cannabinoid Supply with Purisys
|
|
dealer64
|
212 |
54K |
2 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
212
|
54K
|
2
|
|
ASX - By Stock
|
HLS |
Re:
HLS currently doing 2,500 COVID-19 tests a day!
|
|
dealer64
|
44 |
10K |
1 |
27/03/20 |
27/03/20 |
ASX - By Stock
|
44
|
10K
|
1
|
|
ASX - By Stock
|
AVE |
Purdue Bankrupt
|
|
dealer64
|
4 |
3.0K |
2 |
16/09/19 |
16/09/19 |
ASX - By Stock
|
4
|
3.0K
|
2
|
|
ASX - By Stock
|
HLS |
Re:
Helius Greensborough
|
|
dealer64
|
29 |
8.9K |
0 |
11/07/19 |
11/07/19 |
ASX - By Stock
|
29
|
8.9K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
TPM Injectables
|
|
dealer64
|
53 |
19K |
2 |
03/07/19 |
03/07/19 |
ASX - By Stock
|
53
|
19K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Opioids
|
|
dealer64
|
10 |
3.6K |
2 |
27/06/19 |
27/06/19 |
ASX - By Stock
|
10
|
3.6K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Opioids
|
|
dealer64
|
10 |
3.6K |
8 |
26/06/19 |
26/06/19 |
ASX - By Stock
|
10
|
3.6K
|
8
|
|